A detailed history of Gfg Capital, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Gfg Capital, LLC holds 12,830 shares of FGEN stock, worth $4,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,830
Previous 12,830 -0.0%
Holding current value
$4,362
Previous $11,000 54.55%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$0.89 - $2.36 $11,418 - $30,278
12,830 New
12,830 $11,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Gfg Capital, LLC Portfolio

Follow Gfg Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfg Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gfg Capital, LLC with notifications on news.